Royal opening of the new RDC Adore building – bright minds on oncology and neuroscience join forcesAmsterdam, May 14, 2025, Her Majesty Queen Máxima of the Netherlands officially opened the new Research & Diagnostics Center (RDC) Adore today. In this new building of Amsterdam UMC, oncology researchers and neuroscientists will work together under one roof, with one shared goal: to accelerate the development of better, more affordable, and personalized treatments for patients.
Recap of the TN2 SymposiumOn May 8, Linda Douw, chair of the TN2 committee, welcomed all participants to the TN2 symposium at Science Park. Read the summary of the day to get an idea of the topics that were discussed.
New perspective on Multiple Sclerosis: astrocytes, not myelin, as primary targetResearchers from the Amsterdam Leukodystrophy Center have been studying astrocytes for many years. They investigate these cells in the context of a rare genetic disease: Megalencephalic Leukoencephalopathy with subcortical Cysts. In a recently published perspective article in Nature Reviews Neurology, they present a novel insight into the origin of multiple sclerosis (MS), centered around these astrocytes.
